Postoperative pulmonary complications (PPCs), estimated between 2.0% and 5.6% in the
general surgical population and 20–70% for upper abdominal and thoracic surgeries, are a …

Patients with interstitial lung disease (ILD), especially those with pulmonary fibrosis, are at
increased risk of developing lung cancer. Management of lung cancer in patients with ILD is …

Advances in perioperative assessment and diagnostics, together with developments in
anesthetic and surgical techniques, have considerably expanded the pool of patients who …

The coronavirus disease 2019 (COVID-19) pandemic outbreak, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-Cov-2) is affecting people worldwide …

Aim Combining preoperative spirometry with the Assess Respiratory Risk in Surgical
Patients in Catalunia (ARISCAT) risk scale can reduce post-operative complications and …

Purpose Identifying pretreatment interstitial lung abnormalities (ILAs) is important because of
their predictive value for complications after lung cancer treatment. This study aimed to …

Management of idiopathic pulmonary fibrosis (IPF) has rapidly evolved in the past decade,
with 2 disease-modifying pharmacologic therapies now widely available. Despite this …

Purpose The idiopathic interstitial pneumonias (IIP) constitute a large cohort of the over 200
subtypes of interstitial lung disease (ILD). Idiopathic pulmonary fibrosis (IPF) is the most …

Postoperative pulmonary complications (PPCs) arise from a complex interplay of patient,
surgical, and anesthesia-related factors. Despite their significant impact, there are currently …

Background Although acute exacerbation (AE) after treatment for lung cancer (LC) is a poor
prognostic factor in patients with interstitial lung disease associated with lung cancer (ILD …